Del Monte
DMC
29.63
-0.07
-0.24%
Del Monte
US · DMC
#3039 by market cap
Listed 1970
29.63
-0.07
-0.24%
Live - 5344 symbols - heartbeat 346s ago
· 2026-10-07 19:54
After-hours
29.63
0.00%
- Market cap
- 1.40B
- P/E (TTM)i
- 41.73
- P/Bi
- 0.70
- EPSi
- 1.88
- Div yieldi
- 4.05%
- 52W posi
- 21%
Reader sentiment
Are you bullish or bearish on DMC?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.33, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +0.98% YoY
Margins
- Gross margin
- 9.23%
- Operating margin
- 4.31%
- Net margin
- 2.10%
Key ratios & quality
- Enterprise valuei
- 1.58B
- Altman Z-Scorei
- 3.33
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 4.49B | 4.49B | 4.20B | 4.25B | 4.44B | 4.32B | 4.28B | 4.32B |
| Gross profit | 285.90M | 306.40M | 250.90M | 303.80M | 340.20M | 350.70M | 357.90M | 399.10M |
| Selling & admin expenses | 200.80M | 201.50M | 196.20M | 192.90M | 186.80M | 186.70M | 196.90M | 212.70M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 85.10M | 104.90M | 54.70M | 110.90M | 153.40M | 164.00M | 161.00M | 186.40M |
| Pretax profit | 200.00K | 90.70M | 51.30M | 81.90M | 117.80M | 16.50M | 170.70M | 130.90M |
| Tax | 16.10M | 21.40M | 5.00M | 2.00M | 20.10M | 18.10M | 29.10M | 37.40M |
| Net profit | -15.90M | 69.30M | 46.30M | 79.90M | 97.70M | -1.60M | 141.60M | 93.50M |
| Basic EPS | 0 | 1 | 1 | 2 | 2 | 0 | 3 | 2 |
| Diluted EPS | -0.45 | 1.37 | 1.03 | 1.68 | 2.06 | -0.24 | 2.96 | 1.88 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 1.10B | 1.18B | 1.02B | 1.02B | 1.04B | 1.22B |
| Gross profit | 92.20M | 120.10M | 80.80M | 106.00M | 89.00M | 121.30M |
| Selling & admin expenses | 48.10M | 51.30M | 52.10M | 61.20M | 51.10M | 72.60M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 44.10M | 68.80M | 28.70M | 44.80M | 37.90M | 48.70M |
| Pretax profit | 38.80M | 71.50M | -23.90M | 44.50M | 18.50M | 27.60M |
| Tax | 6.90M | 14.10M | 4.20M | 12.20M | 7.80M | 6.10M |
| Net profit | 31.90M | 57.40M | -28.10M | 32.30M | 10.70M | 21.50M |
| Basic EPS | 1 | 1 | -1 | 1 | 0 | 0 |
| Diluted EPS | 0.64 | 1.18 | -0.61 | 0.67 | 0.21 | 0.44 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.14B | 1.05B | 1.01B | 1.10B | 1.24B | 1.14B | 1.13B | 1.14B |
| Cash & ST investments | 21.30M | 33.30M | 16.50M | 16.10M | 17.20M | 33.80M | 32.60M | 35.70M |
| Inventory | 565.30M | 551.80M | 507.70M | 602.80M | 669.00M | 599.90M | 595.30M | 581.90M |
| Total assets | 3.26B | 3.35B | 3.26B | 3.40B | 3.46B | 3.18B | 3.10B | 3.06B |
| Total current liabilities | 586.00M | 562.90M | 554.80M | 629.20M | 607.00M | 540.60M | 533.10M | 529.30M |
| Short-term debt | 500.00K | 32.80M | 29.00M | 38.30M | 42.90M | 50.00M | 40.10M | 46.90M |
| Long-term debt | 661.90M | 586.80M | 541.80M | 527.70M | 547.10M | 406.10M | 248.90M | 176.20M |
| Total liabilities | 1,485,600,000.00 | 1,550,900,000.00 | 1,463,400,000.00 | 1,524,600,000.00 | 1,483,900,000.00 | 1,271,400,000.00 | 1,089,400,000.00 | 1,028,800,000.00 |
| Total equity | 1.77B | 1.80B | 1.80B | 1.87B | 1.98B | 1.91B | 2.01B | 2.03B |
| Retained earnings | 1.21B | 1.25B | 1.27B | 1.33B | 1.40B | 1.34B | 1.44B | 1.45B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.19B | 1.18B | 1.17B | 1.14B | 1.38B | 1.35B |
| Cash & ST investments | 34.40M | 85.50M | 97.20M | 35.70M | 66.30M | 36.10M |
| Inventory | 603.30M | 552.20M | 569.50M | 581.90M | 728.40M | 721.40M |
| Total assets | 3.15B | 3.16B | 3.07B | 3.06B | 3.40B | 3.38B |
| Total current liabilities | 580.60M | 567.70M | 557.70M | 529.30M | 588.10M | 606.10M |
| Short-term debt | 39.30M | 38.40M | 38.20M | 46.90M | 53.50M | 51.20M |
| Long-term debt | 237.40M | 205.20M | 176.70M | 176.20M | 451.50M | 426.40M |
| Total liabilities | 1,131,100,000.00 | 1,086,600,000.00 | 1,036,300,000.00 | 1,028,800,000.00 | 1,372,900,000.00 | 1,360,300,000.00 |
| Total equity | 2.02B | 2.08B | 2.03B | 2.03B | 2.03B | 2.02B |
| Retained earnings | 1.45B | 1.49B | 1.44B | 1.45B | 1.44B | 1.44B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 246.60M | 169.10M | 180.60M | 128.50M | 61.80M | 177.90M | 182.50M | 245.10M |
| Depreciation & amortization | 100.50M | 97.90M | 95.00M | 96.80M | 92.50M | 84.80M | 78.50M | 72.50M |
| Free cash flow | 96.10M | 46.80M | 30.60M | 30.00M | 13.70M | 120.20M | 130.80M | 181.30M |
| Dividends paid | -29.00M | -6.70M | -14.30M | -23.70M | -28.70M | -35.90M | -47.80M | -57.40M |
| Stock buybacks / issuance | -29.40M | -17.90M | -20.80M | 0 | 0 | -11.80M | 0 | -29.80M |
| Ending cash balance | 21.30M | 33.30M | 16.50M | 16.10M | 17.20M | 33.80M | 32.60M | 64.20M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 46.10M | 113.10M | 75.00M | 10.90M | 44.10M | 49.90M |
| Depreciation & amortization | 18.50M | 18.40M | 18.30M | 17.30M | 16.10M | 20.30M |
| Free cash flow | 36.10M | 101.50M | 60.90M | -17.20M | 29.70M | 24.10M |
| Dividends paid | -14.40M | -14.40M | -14.30M | -14.30M | -14.20M | -14.30M |
| Stock buybacks / issuance | -7.60M | 0 | -7.20M | -15.00M | -4.00M | -16.10M |
| Ending cash balance | 34.40M | 85.50M | 97.20M | 64.20M | 69.80M | 39.60M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -1.27 | 3.90 | 2.85 | 4.53 | 5.32 | -0.60 | 7.32 | 4.53 |
| ROA %i | -0.73 | 2.01 | 1.47 | 2.37 | 2.88 | -0.34 | 4.53 | 2.95 |
| ROIC %i | -0.24 | 3.55 | 2.80 | 4.04 | 4.60 | 0.25 | 6.39 | 4.09 |
| 5-year avg ROE %i | 6.05 | 5.18 | 5.03 | 3.36 | 3.07 | 3.20 | 3.88 | 4.22 |
| EBIT margin %i | 0.53 | 2.59 | 1.71 | 2.39 | 3.20 | 0.94 | 4.42 | 3.29 |
| FCF / sales %i | 2.14 | 1.04 | 0.73 | 0.71 | 0.31 | 2.78 | 3.06 | 4.19 |
| Current ratioi | 1.94 | 1.87 | 1.82 | 1.74 | 2.05 | 2.12 | 2.13 | 2.16 |
| Quick ratioi | 0.84 | 0.84 | 0.81 | 0.72 | 0.79 | 0.95 | 0.95 | 0.94 |
| Debt / assetsi | 20.35 | 21.56 | 21.00 | 20.66 | 21.32 | 18.79 | 13.28 | 11.41 |
| LT debt / equityi | 39.12 | 40.11 | 37.97 | 36.83 | 36.46 | 28.91 | 18.65 | 14.98 |
| Interest coveragei | 1.01 | 4.57 | 3.48 | 5.16 | 5.83 | 1.68 | 10.28 | 12.69 |
| Revenue CAGR (3Y) %i | 3.47 | 3.82 | 0.94 | -1.83 | -0.35 | 0.93 | 0.22 | -0.91 |
| Net income CAGR (3Y) %i | -- | -33.40 | -25.87 | -- | 14.03 | -- | 21.14 | -2.75 |
| FCF CAGR (3Y) %i | -3.09 | -38.16 | -18.10 | -32.16 | -33.60 | 57.78 | 63.37 | 136.53 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 7.51 | 7.49 | 3.95 | 4.53 | 3.46 | 1.67 |
| ROA %i | 4.63 | 4.79 | 2.55 | 2.95 | 2.12 | 1.04 |
| ROIC %i | 6.52 | 6.67 | 3.66 | 4.09 | 2.96 | 1.62 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 4.56 | 4.61 | 2.85 | 3.29 | 2.83 | 1.86 |
| FCF / sales %i | 3.77 | 3.37 | 4.08 | 4.19 | 4.10 | 2.27 |
| Current ratioi | 2.05 | 2.08 | 2.09 | 2.16 | 2.34 | 2.23 |
| Quick ratioi | 0.94 | 1.05 | 0.97 | 0.94 | 1.02 | 0.93 |
| Debt / assetsi | 12.85 | 11.75 | 10.93 | 11.41 | 18.48 | 17.59 |
| LT debt / equityi | 18.24 | 16.18 | 14.74 | 14.98 | 28.56 | 27.09 |
| Interest coveragei | 11.73 | 13.52 | 9.62 | 12.69 | 12.06 | 6.01 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Fresh and value-added products is the largest reported line at 46.70% of revenue, across 4 reported segments.
- Banana follows at 29.62%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Fresh and value-added products46.70%
Banana29.62%
Prepared foods19.37%
Other products and services4.31%
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.